| Associates For Behavioral Health | |
|
1510 Boyson Rd Hiawatha IA 52233-2310 | |
| (319) 396-1066 | |
| (319) 396-8779 |
| Full Name | Associates For Behavioral Health |
|---|---|
| Speciality | Clinic/Center |
| Location | 1510 Boyson Rd, Hiawatha, Iowa |
| Authorized Official Name and Position | Thomas Kremer (CLINICAL DIRECTOR) |
| Authorized Official Contact | 3193961066 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Associates For Behavioral Health 740 N 15th Ave Ste A Hiawatha IA 52233-2384 Ph: (319) 396-1066 | Associates For Behavioral Health 1510 Boyson Rd Hiawatha IA 52233-2310 Ph: (319) 396-1066 |
| NPI Number | 1811998859 |
|---|---|
| Provider Enumeration Date | 08/01/2005 |
| Last Update Date | 02/28/2024 |
| Certification Date | 02/28/2024 |
| Medicare PECOS PAC ID | 0446140222 |
|---|---|
| Medicare Enrollment ID | O20040316001232 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811998859 | NPI | - | NPPES |
| 10474 | Other | IA | BCBS |
| 0263897 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QM0801X | Clinic/center - Mental Health (including Community Mental Health Center) | (* (Not Available)) | Primary |
| Provider Name | Alan C Whitters |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1093778532 PECOS PAC ID: 6608840830 Enrollment ID: I20050711000850 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Jeffrey D Wilharm |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1982605762 PECOS PAC ID: 7012946858 Enrollment ID: I20050811000477 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Mark W Mittauer |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1255322996 PECOS PAC ID: 4587730791 Enrollment ID: I20080911000248 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Jessica Lynn Blake |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1013142991 PECOS PAC ID: 6709930175 Enrollment ID: I20090819000595 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Ali Safdar |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1043211303 PECOS PAC ID: 5890824379 Enrollment ID: I20100520000884 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Dwight J Schroeder |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1528047081 PECOS PAC ID: 9234103466 Enrollment ID: I20100527000535 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Karen L Penick |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1225020092 PECOS PAC ID: 8628108610 Enrollment ID: I20100618000208 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Trina Lynn Reiter |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1144221490 PECOS PAC ID: 6305977737 Enrollment ID: I20100629000868 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Edgar Siguenza |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1962403220 PECOS PAC ID: 2668503822 Enrollment ID: I20100701000664 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Evans K Komen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1003216839 PECOS PAC ID: 7911129432 Enrollment ID: I20141117000608 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Elizabeth Breen |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1245787142 PECOS PAC ID: 4981940103 Enrollment ID: I20190109001753 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Amy Morin |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1629617469 PECOS PAC ID: 1557799228 Enrollment ID: I20200311000645 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Wendy S Murray |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1215665930 PECOS PAC ID: 3173991395 Enrollment ID: I20221119000284 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Tamara K Lauritzen |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1801546494 PECOS PAC ID: 5597135798 Enrollment ID: I20230104002417 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Devon R Steen |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1043808603 PECOS PAC ID: 0042685083 Enrollment ID: I20230405001501 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Bailey J Zaruba |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1053099051 PECOS PAC ID: 3870954738 Enrollment ID: I20230725003822 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Toni S Neta |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1134120405 PECOS PAC ID: 9133158967 Enrollment ID: I20231122000994 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | Ingrid Conway |
|---|---|
| Provider Type | Practitioner - Marriage And Family Therapist |
| Provider Identifiers | NPI Number: 1104224583 PECOS PAC ID: 6204284672 Enrollment ID: I20231122002955 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | John W Sondag |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1912125360 PECOS PAC ID: 1456454511 Enrollment ID: I20231128001386 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
| Provider Name | William Klima |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1720454242 PECOS PAC ID: 1456701713 Enrollment ID: I20231228001969 |
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
News Archive
The Northeast Assisted Fertility Group (NAFG), already among the leading surrogacy and egg donation programs in the United States, is pleased to announce its enhanced International Program, extending a more complete menu of services to citizens of England, France, Italy, Spain, Switzerland, Germany, Australia, and other countries where the practice of egg donation and surrogacy is restricted or very limited.
Cancer biologists are turning their attention to the normal cells that give rise to cancers, to learn more about how tumor growth might be stopped at the earliest opportunity.
Scope, the leading national disability organisation, today launches its Time To Get Equal campaign to end discrimination and prejudice against the UK's 10 million disabled people.
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have discovered that a protein, zyxin, is necessary for the maintenance and repair of the cell's cytoskeleton, or internal framework, which serves as the muscle and bone of the cell. The research has implications for cancer, as well as other diseases, since alterations in the cytoskeleton are often associated with disease. The research was published in the Sep. 14, 2010, issue of the journal Developmental Cell.
A drug that acts like a growth-promoting protein in the brain reduces degeneration and motor deficits associated with Huntington's disease in two mouse models of the disorder, according to a study appearing November 27 in the Journal of Neuroscience. The findings add to a growing body of evidence that protecting or boosting neurotrophins - the molecules that support the survival and function of nerve cells - may slow the progression of Huntington's disease and other neurodegenerative disorders.
› Verified 8 days ago
Abbe Center At St Lukes Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1077 N Center Point Rd, Hiawatha, IA 52233 Phone: 319-369-7952 | |
Resilience Family Counseling, Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1560 Boyson Rd Ste 2, Hiawatha, IA 52233 Phone: 319-294-9206 Fax: 319-294-6107 | |
Prism Therapy Group Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1089 Longfellow Dr Ste C, Hiawatha, IA 52233 Phone: 319-361-9381 | |
Mwr Counseling Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1811 Boyson Rd, Suite A, Hiawatha, IA 52233 Phone: 319-250-1267 Fax: 319-200-4456 | |
Cbt Specialty Services Of Iowa, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1811 Boyson Rd, Hiawatha, IA 52233 Phone: 319-540-7123 | |
St. Luke's Hospital Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1077 N Center Point Rd, Hiawatha, IA 52233 Phone: 319-369-7952 Fax: 319-368-5643 |